Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Galipeau

Showing results (81-90 of 193) with videos related to

Pageof 20
Sort By:
Blood|November 4, 2006
A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complexMoutih Rafei, Jian Hui Wu, Borhane Annabi, et al.
Cytotherapy|April 24, 2017
Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experienceLaurie S Conklin, Patrick J Hanley, Jacques Galipeau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 10, 2015
Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive ActivityIan B Copland, Muna Qayed, Marco A Garcia, et al.
Cancer Research|January 14, 2012
B effector cells activated by a chimeric protein consisting of IL-2 and the ectodomain of TGF-β receptor II induce potent antitumor immunityClaudia Penafuerte, Spencer Ng, Norma Bautista-Lopez, et al.
Rheumatology (Oxford, England)|February 26, 2022
Ruxolitinib inhibits IFNγ-stimulated Sjögren's salivary gland MSC HLA-DR expression and chemokine-dependent T cell migrationSara S McCoy, Maxwell Parker, Ilya Gurevic, et al.
Cell Communication & Adhesion|April 15, 2006
Connexin over-expression differentially suppresses glioma growth and contributes to the bystander effect following HSV-thymidine kinase gene therapyTomas Jimenez, W Paul Fox, Christian C G Naus, et al.
Plos One|July 12, 2013
Properties of immature myeloid progenitors with nitric-oxide-dependent immunosuppressive activity isolated from bone marrow of tumor-free miceParvin Forghani, Wayne Harris, Cynthia R Giver, et al.
Stem Cells (Dayton, Ohio)|May 21, 2019
Potency Analysis of Mesenchymal Stromal Cells Using a Phospho-STAT Matrix Loop Analytical ApproachRaghavan Chinnadurai, Augustine Rajakumar, Andrew J Schneider, et al.
Neurourology and Urodynamics|March 18, 2011
Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinenceJacques Corcos, Oleg Loutochin, Lysanne Campeau, et al.
Biomaterials|July 30, 2013
The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapyIan B Copland, Marco A Garcia, Edmund K Waller, et al.
Pageof 20

Showing results (81-90 of 193) with videos related to

Sort By:
Pageof 20
Blood|November 4, 2006
A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complexMoutih Rafei, Jian Hui Wu, Borhane Annabi, et al.
Cytotherapy|April 24, 2017
Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experienceLaurie S Conklin, Patrick J Hanley, Jacques Galipeau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 10, 2015
Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive ActivityIan B Copland, Muna Qayed, Marco A Garcia, et al.
Cancer Research|January 14, 2012
B effector cells activated by a chimeric protein consisting of IL-2 and the ectodomain of TGF-β receptor II induce potent antitumor immunityClaudia Penafuerte, Spencer Ng, Norma Bautista-Lopez, et al.
Rheumatology (Oxford, England)|February 26, 2022
Ruxolitinib inhibits IFNγ-stimulated Sjögren's salivary gland MSC HLA-DR expression and chemokine-dependent T cell migrationSara S McCoy, Maxwell Parker, Ilya Gurevic, et al.
Cell Communication & Adhesion|April 15, 2006
Connexin over-expression differentially suppresses glioma growth and contributes to the bystander effect following HSV-thymidine kinase gene therapyTomas Jimenez, W Paul Fox, Christian C G Naus, et al.
Plos One|July 12, 2013
Properties of immature myeloid progenitors with nitric-oxide-dependent immunosuppressive activity isolated from bone marrow of tumor-free miceParvin Forghani, Wayne Harris, Cynthia R Giver, et al.
Stem Cells (Dayton, Ohio)|May 21, 2019
Potency Analysis of Mesenchymal Stromal Cells Using a Phospho-STAT Matrix Loop Analytical ApproachRaghavan Chinnadurai, Augustine Rajakumar, Andrew J Schneider, et al.
Neurourology and Urodynamics|March 18, 2011
Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinenceJacques Corcos, Oleg Loutochin, Lysanne Campeau, et al.
Biomaterials|July 30, 2013
The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapyIan B Copland, Marco A Garcia, Edmund K Waller, et al.
Pageof 20